Suppr超能文献

5-羟色胺3(5-HT3)受体拮抗剂KB-R6933对实验性腹泻模型的影响。

Effect of the 5-hydroxytryptamine3 (5-HT3)-receptor antagonist KB-R6933 on experimental diarrhea models.

作者信息

Ozaki A, Yoshidomi M, Sukamoto T

机构信息

Pharmaceuticals R&D Center, Kanebo, Ltd., Osaka, Japan.

出版信息

Jpn J Pharmacol. 1999 May;80(1):93-6. doi: 10.1254/jjp.80.93.

Abstract

The effects of a 5-hydroxytryptamine3 (5-HT3)-receptor antagonist KB-R6933 (6-amino-5-chloro-1-isopropyl-2-(4-methyl-1-piperazinyl)-benzimidazole dimaleate) on experimental diarrhea and on intestinal fluid secretion stimulated by cholera toxin were examined and compared with those of ramosetron and loperamide. KB-R6933 and ramosetron (0.03-1 mg/kg, p.o.) inhibited the diarrhea induced by 5-HT, but not that by castor oil or prostaglandin E2 (PGE2), in mice. Loperamide significantly inhibited the diarrhea induced by 5-HT, castor oil and PGE2. All drugs tested inhibited the diarrhea induced by restraint stress and the intestinal fluid secretion stimulated by cholera toxin in rats. The results suggest the possibility that KB-R6933 may have clinical efficacy in the treatment of diarrhea.

摘要

研究了5-羟色胺3(5-HT3)受体拮抗剂KB-R6933(6-氨基-5-氯-1-异丙基-2-(4-甲基-1-哌嗪基)-苯并咪唑二马来酸盐)对实验性腹泻以及霍乱毒素刺激引起的肠液分泌的影响,并与雷莫司琼和洛哌丁胺进行了比较。在小鼠中,KB-R6933和雷莫司琼(0.03-1mg/kg,口服)可抑制5-羟色胺引起的腹泻,但对蓖麻油或前列腺素E2(PGE2)引起的腹泻无抑制作用。洛哌丁胺可显著抑制5-羟色胺、蓖麻油和PGE2引起的腹泻。所有受试药物均能抑制大鼠束缚应激引起的腹泻以及霍乱毒素刺激引起的肠液分泌。结果提示KB-R6933在治疗腹泻方面可能具有临床疗效。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验